Anixa Biosciences, Inc.
ANIX
$2.60
-$0.16-5.80%
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.18M | -2.88M | -3.28M | -3.14M | -3.26M |
| Total Depreciation and Amortization | 9.00K | 9.00K | 3.00K | 12.00K | 13.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 774.00K | 974.00K | 1.24M | 1.22M | 1.23M |
| Change in Net Operating Assets | -503.00K | 973.00K | -607.00K | 452.00K | -292.00K |
| Cash from Operations | -2.90M | -927.00K | -2.64M | -1.46M | -2.31M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.70M | 867.00K | 2.72M | 556.00K | 129.00K |
| Cash from Investing | 2.70M | 867.00K | 2.72M | 556.00K | 129.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 194.00K | 991.00K | 67.00K |
| Repurchase of Common Stock | -- | -33.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -17.00K | 139.00K | -45.00K | -94.00K | 2.20M |
| Cash from Financing | -17.00K | 106.00K | 149.00K | 897.00K | 2.26M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -218.00K | 46.00K | 230.00K | -3.00K | 83.00K |
